The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((trans-4-Hydroxycyclohexyl)amino)-4-(3-isopropyl-4-(quinolin-3-yl)-1H-indazol-1-yl)benzamide ID: ALA4570276
PubChem CID: 155562486
Max Phase: Preclinical
Molecular Formula: C32H33N5O2
Molecular Weight: 519.65
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1nn(-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)c2cccc(-c3cnc4ccccc4c3)c12
Standard InChI: InChI=1S/C32H33N5O2/c1-19(2)31-30-25(21-16-20-6-3-4-8-27(20)34-18-21)7-5-9-29(30)37(36-31)23-12-15-26(32(33)39)28(17-23)35-22-10-13-24(38)14-11-22/h3-9,12,15-19,22,24,35,38H,10-11,13-14H2,1-2H3,(H2,33,39)/t22-,24-
Standard InChI Key: IMWOPWTYPKQKDQ-HCGLCNNCSA-N
Molfile:
RDKit 2D
39 44 0 0 0 0 0 0 0 0999 V2000
29.4959 -4.3624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4947 -5.1820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2028 -5.5909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2010 -3.9536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1957 -3.1392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9039 -2.7291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9018 -1.9127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4891 -2.7356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4835 -1.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1917 -1.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1857 -0.6871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4722 -0.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7634 -0.7017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7729 -1.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9096 -4.3588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9144 -5.1775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6944 -5.4259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1718 -4.7608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6867 -4.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9502 -6.1970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4052 -6.8074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6616 -7.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4627 -7.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0068 -7.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7475 -6.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7208 -8.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1783 -9.1350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5213 -8.6880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8077 -7.2955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3488 -6.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1486 -6.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6888 -6.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4330 -5.4647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6315 -5.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0860 -5.9121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9764 -4.8544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9347 -3.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7330 -3.1481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5187 -2.7187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 16 2 0
15 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
4 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
17 20 1 0
23 26 1 0
26 27 1 0
26 28 2 0
24 29 1 0
30 29 1 1
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
33 36 1 6
19 37 1 0
37 38 1 0
37 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 519.65Molecular Weight (Monoisotopic): 519.2634AlogP: 6.18#Rotatable Bonds: 6Polar Surface Area: 106.06Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.02CX LogP: 5.64CX LogD: 5.64Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.25Np Likeness Score: -0.88
References 1. Uno T, Kawai Y, Yamashita S, Oshiumi H, Yoshimura C, Mizutani T, Suzuki T, Chong KT, Shigeno K, Ohkubo M, Kodama Y, Muraoka H, Funabashi K, Takahashi K, Ohkubo S, Kitade M.. (2019) Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor., 62 (2): [PMID:30525599 ] [10.1021/acs.jmedchem.8b01085 ]